| Net Cash Provided by (Used in) Financing Activities |
$94,750 |
USD |
-53% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$7,712 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
350,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
27,154,508 |
shares |
49% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,759 |
USD |
1122% |
Q4 2025 |
Q2 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$255 |
USD |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,843,030 |
USD |
61% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Gross |
$2,843,030 |
USD |
61% |
Q4 2025 |
Q2 2026 |
| Depreciation |
$41,810 |
USD |
|
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q3 2024 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
$1,167,352 |
USD |
|
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$7,023,798 |
USD |
|
Q2 2024 |
FY 2024 |
| Current Income Tax Expense (Benefit) |
$623,851 |
USD |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$9,853,732 |
USD |
65% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2025 |
Q2 2026 |
| Share-based Payment Arrangement, Expense |
$259,500 |
USD |
-7.8% |
Q4 2025 |
Q2 2026 |
| Interest Expense |
$77,787 |
USD |
376% |
Q4 2025 |
Q2 2026 |